Recombinant IgE (Tanezumab Biosimilar) antibody

Catalog No. ABIN7598023

The Humanized Chimeric anti-IgE (Tanezumab Biosimilar) antibody has been validated for . It is suitable to detect IgE (Tanezumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IgE (Tanezumab Biosimilar) antibody (ABIN7598023)

Target: IgE (Tanezumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IgE (Tanezumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-IgE (Tanezumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Tanezumab Biosimilar Antibody

Specificity: Beta-nerve growth factor, NGFB, Beta-NGF, NGF

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.54 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IgE (Tanezumab Biosimilar)

Target: IgE (Tanezumab Biosimilar)

Alternative Name: Tanezumab Biosimilar

Target Type: Biosimilar

Background: Beta-nerve growth factor, NGFB, Beta-NGF, NGF

UniProt: P01138

CAS-No: 880266-57-9